Interferon production linked to toxicity of polyriboinosinic acid-polyribocytidylic acid.
Different procedures have been used in attempts to increase the production of interferon by polyriboinosinic acid-polyribocytidylic acid (poly [rI].poly [rC]) in mice: simultaneous injection of lead acetate, cycloheximide, or actinomycin D and prior injection of Freund's adjuvant, chlorite-oxidized oxyamylose (COAM), endotoxin, or Brucella abortus. In the experimental conditions tested, lead acetate, cycloheximide, Freund's adjuvant, and COAM brought about a parallel increase in interferon production and toxicity (lethality) of poly (rI).poly (rC); actinomycin D, endotoxin, and B. abortus increased the lethality of poly (rI).poly (rC) without a concomitant raise of its interferon-inducing capacity. Our results indicate that no significant increase in interferon production (or antiviral activity, as far as the antiviral activity is accounted for by interferon production) without an accompanying increase in toxicity can be achieved with poly (rI).poly (rC) and that it might be impossible to increase its therapeutic ratio (ratio of maximum tolerated dose to minimum effective dose).
D000818:Animals; D002006:Brucellosis / Q000401:mortality; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004731:Endotoxins / Q000009:adverse effects; D005260:Female; D005620:Freund's Adjuvant / Q000494:pharmacology; D007369:Interferon Inducers / Q000494:pharmacology / Q000633:toxicity; D007372:Interferons / Q000096:biosynthesis* / Q000097:blood / Q000494:pharmacology; D007928:Lethal Dose 50; D051379:Mice; D008815:Mice, Inbred Strains; D011070:Poly I-C / Q000008:administration & dosage / Q000633:toxicity*; D012477:Salmonella enteritidis
D004731:Endotoxins; D007369:Interferon Inducers; D003609:Dactinomycin; D005620:Freund's Adjuvant; D007372:Interferons; D003513:Cycloheximide; D011070:Poly I-C